Metformin for diabetes from chronic pancreatitis
Treatments studied
Part of Digestive system clinical trials.
This trial tests if metformin is safe and effective for people who developed diabetes after being diagnosed with chronic pancreatitis. You must not have taken any diabetes medication before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with chronic pancreatitis.
- Your diabetes was diagnosed at least 3 months after your pancreatitis diagnosis.
- You have never taken any diabetes medication, or you stopped taking it at least 8 weeks ago.
- Your HbA1c level is between 7.5% and 9.0%.
- Your BMI is above 18.5.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood sugar and certain hormones change in people who have both chronic pancreatitis and diabetes. It aims to understand these patterns better, which might help design future treatments.
This study uses a special blood-sugar test (a mixed meal) to better diagnose and understand diabetes related to pancreatic cancer or chronic pancreatitis, and to compare it with other diabetes types. It may help researchers find clearer ways to tell these diabetes causes apart and understand how they work.
This trial tests whether pirfenidone, an oral medication that may reduce scarring and inflammation, can help relieve pain in people with chronic pancreatitis. If you have ongoing pain or frequent flare-ups, this study could offer a new treatment option.
This study explores how the pancreas and diabetes are connected by examining people with different pancreatic conditions. It aims to find new ways to treat or prevent diabetes.
This study looks at how chronic pancreatitis affects blood sugar and digestion. It tests if your body makes enough enzymes and how your sugar control changes over time.
This trial tests whether pioglitazone or empagliflozin is better at managing diabetes caused by chronic or recurrent pancreatitis. You will take one of these pills daily for 6 months and track your blood sugar and ketones at home. The goal is to find a safer, more effective treatment for this type of diabetes.
Hear when a new Chronic Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.